We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current REVBW market cap is 119.64k. The company's latest EPS is USD -0.0191 and P/E is -1.05.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.22M | -1.62M | -1.93M | -2.78M | -2.33M |
| Net Income | -1.21M | 6.16M | -1.45M | -2.63M | -2.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4k | -145k | -3.09M | -10.87M | -8.66M |
| Net Income | -4k | -136k | -2.13M | -10.83M | -120k |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.5M | 18.12M | 16.04M | 14.22M | 12.21M |
| Total Liabilities | 4.45M | 8.1M | 4.62M | 5.4M | 5.57M |
| Total Equity | 1.05M | 10.02M | 11.42M | 8.82M | 6.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23k | 74.16M | 48.39M | 5.5M | 12.21M |
| Total Liabilities | 27k | 2.95M | 8.4M | 4.45M | 5.57M |
| Total Equity | -4k | 5M | -7.82M | 1.05M | 6.65M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.22M | -1.58M | -3.57M | -5.28M | -7.29M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 15.2M | 14.03M | 14.03M | 14.03M | 14.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -219k | -726k | -11.22M | -7.29M |
| Investing | N/A | -74.04M | 25.74M | N/A | N/A |
| Financing | N/A | 74.27M | -24.95M | 15.2M | 14.03M |
| Market Cap | 119.64k |
| Price to Earnings Ratio | -1.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.01 |
| Price to Book Ratio | 0.02 |
| Dividend Yield | - |
| Shares Outstanding | 6.3M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (62.24%) |
| Company Name | Revelation Biosciences Inc |
| Address |
16192 coastal hwy lewes, delaware 19958 |
| Website | https:// |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
